{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:15:28Z","timestamp":1790936128388,"version":"4.1.0"},"reference-count":185,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1053\/j.seminhematol.2008.12.005","type":"journal-article","created":{"date-parts":[[2009,2,25]],"date-time":"2009-02-25T04:42:52Z","timestamp":1235536972000},"page":"S2-S14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":197,"special_numbering":"S2","title":["Pathobiology of Secondary Immune Thrombocytopenia"],"prefix":"10.1053","volume":"46","author":[{"given":"Douglas B.","family":"Cines","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Liebman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Stasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2008.12.005_bib1","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1056\/NEJMra010501","article-title":"Immune thrombocytopenic purpura","volume":"346","author":"Cines","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V88.1.3.3","article-title":"Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology","volume":"88","author":"George","year":"1996","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib3","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1046\/j.1365-2141.2003.04131.x","article-title":"Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy","volume":"120","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib4","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1182\/blood-2007-05-088500","article-title":"Historical review: megakaryopoiesis and thrombopoiesis","volume":"111","author":"Kaushansky","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib5","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/344444a0","article-title":"Expression of an erythroid transcription factor in megakaryocytic and mast cell lineages","volume":"344","author":"Martin","year":"1990","journal-title":"Nature"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0092-8674(00)80318-9","article-title":"FOG, a multitype zinc finger protein, acts as a cofactor for transcription factor GATA-1 in erythroid and megakaryocytic differentiation","volume":"90","author":"Tsang","year":"1997","journal-title":"Cell"},{"issue":"Suppl 1","key":"10.1053\/j.seminhematol.2008.12.005_bib7","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/stem.5530140724","article-title":"The platelet glycoprotein Ib-V-IX system: regulation of gene expression","volume":"14","author":"Roth","year":"1996","journal-title":"Stem Cells"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib8","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1182\/blood.V95.3.769.003a49_769_775","article-title":"Stromal cell-derived factor-1 (SDF-1) acts together with thrombopoietin to enhance the development of megakaryocytic progenitor cells (CFU-MK)","volume":"95","author":"Hodohara","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib9","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1182\/blood.V85.7.1719.bloodjournal8571719","article-title":"Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro","volume":"85","author":"Broudy","year":"1995","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib10","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1073\/pnas.92.8.3234","article-title":"Thrombopoietin, the Mp1 ligand, is essential for full megakaryocyte development","volume":"92","author":"Kaushansky","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib11","doi-asserted-by":"crossref","first-page":"5292","DOI":"10.1073\/pnas.92.12.5292","article-title":"Distinct regions of c-Mpl cytoplasmic domain are coupled to the JAK-STAT signal transduction pathway and Shc phosphorylation","volume":"92","author":"Gurney","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0014-5793(95)00796-C","article-title":"Thrombopoietin (TPO) induces tyrosine phosphorylation and activation of STAT5 and STAT3","volume":"370","author":"Bacon","year":"1995","journal-title":"FEBS Lett"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib13","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1182\/blood.V85.12.3444.bloodjournal85123444","article-title":"Thrombopoietin induces tyrosine phosphorylation and activation of the Janus kinase, JAK2","volume":"85","author":"Tortolani","year":"1995","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib14","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1182\/blood.V89.2.483","article-title":"Thrombopoietin signal transduction in purified murine megakaryocytes","volume":"89","author":"Drachman","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib15","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0014-5793(95)01386-5","article-title":"Thrombopoietin induces activation of at least two distinct signaling pathways","volume":"377","author":"Nagata","year":"1995","journal-title":"FEBS Lett"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4161\/cc.7.2.5148","article-title":"PI3K\/Akt\/FOXO3a pathway contributes to thrombopoietin-induced proliferation of primary megakaryocytes in vitro and in vivo via modulation of p27(Kip1)","volume":"7","author":"Nakao","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib17","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.cellsig.2005.09.010","article-title":"Thrombopoietin (TPO) induces c-myc expression through a","volume":"18","author":"Chanprasert","year":"2006","journal-title":"Cell Signal"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib18","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/MOH.0b013e3282bad151","article-title":"Delivering new insight into the biology of megakaryopoiesis and thrombopoiesis","volume":"14","author":"Battinelli","year":"2007","journal-title":"Curr Opin Hematol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib19","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/MOH.0b013e3282ba5552","article-title":"Pathogenesis of chronic immune thrombocytopenic purpura","volume":"14","author":"Cines","year":"2007","journal-title":"Curr Opin Hematol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib20","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/ajcp\/64.2.180","article-title":"Structure of the spleen in idiopathic thrombocytopenic purpura","volume":"64","author":"Tavassoli","year":"1975","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib21","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJM197405022901803","article-title":"Phagocytosis of antibody-coated platelets by human granulocytes","volume":"290","author":"Handin","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJM197401312900505","article-title":"In vitro platelet phagocytosis by splenic leukocytes in idiopathic thrombocytopenic purpura","volume":"290","author":"McMillan","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0037-1963(00)90102-1","article-title":"Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura","volume":"37","author":"McMillan","year":"2000","journal-title":"Semin Hematol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib24","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1182\/blood.V83.4.1024.1024","article-title":"Spectrum of Ig classes, specificities, and titers of serum antiglycoproteins in chronic idiopathic thrombocytopenic purpura","volume":"83","author":"He","year":"1994","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib25","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1182\/blood-2007-12-129262","article-title":"Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab","volume":"112","author":"Stasi","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib26","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1182\/blood-2007-02-068999","article-title":"Response to B-cell depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura","volume":"110","author":"Stasi","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib27","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0163-4453(84)94147-1","article-title":"Varicella-induced thrombocytopenia","volume":"8","author":"Ho-Yen","year":"1984","journal-title":"J Infect"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib28","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1182\/blood-2003-07-2367","article-title":"Platelet-associated CD154 in immune thrombocytopenic purpura","volume":"105","author":"Solanilla","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib29","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1034\/j.1600-0609.2002.02774.x","article-title":"Significance of chemokines and soluble CD40 ligand in patients with autoimmune thrombocytopenic purpura","volume":"69","author":"Nagahama","year":"2002","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib30","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1182\/blood.V100.4.1388.h81602001388_1388_1398","article-title":"Genetic analysis of autoantibodies in idiopathic thrombocytopenic purpura reveals evidence of clonal expansion and somatic mutation","volume":"100","author":"Roark","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib31","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1182\/blood-2008-02-139402","article-title":"Recruitment of T cells into bone marrow of ITP patients possibly due to elevated expression of VLA-4 and CX3CR1","volume":"112","author":"Olsson","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib32","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/nm921","article-title":"T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura","volume":"9","author":"Olsson","year":"2003","journal-title":"Nat Med"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib33","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1600-0609.2005.00622.x","article-title":"Cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura","volume":"76","author":"Zhang","year":"2006","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib34","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1182\/blood.V65.3.584.584","article-title":"Platelet kinetics in patients with idiopathic thrombocytopenic purpura and moderate thrombocytopenia","volume":"65","author":"Stoll","year":"1985","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib35","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1182\/blood-2003-08-2672","article-title":"Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP","volume":"103","author":"McMillan","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1172\/JCI113060","article-title":"Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura","volume":"80","author":"Ballem","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib37","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1055\/s-0038-1656057","article-title":"Serum thrombopoietin level is not regulated by transcription but by the total counts of both megakaryocytes and platelets during thrombocytopenia and thrombocytosis","volume":"77","author":"Nagata","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib38","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1046\/j.1365-2141.1996.d01-1702.x","article-title":"Circulating thrombopoietin level in chronic immune thrombocytopenic purpura","volume":"93","author":"Kosugi","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib39","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1182\/blood.V87.10.4068.bloodjournal87104068","article-title":"Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction","volume":"87","author":"Emmons","year":"1996","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib40","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1182\/blood-2002-05-1475","article-title":"Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro","volume":"102","author":"Chang","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib41","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1182\/blood-2003-01-0275","article-title":"Ultrastructural study shows morphologic features of apoptosis and para-apoptosis in megakaryocytes from patients with idiopathic thrombocytopenic purpura","volume":"103","author":"Houwerzijl","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib42","first-page":"605","article-title":"Prevalence and significance of haematological abnormalities in patients with systemic lupus erythematosus","volume":"80","author":"Nossent","year":"1991","journal-title":"Q J Med"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib43","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1002\/art.10420","article-title":"Autoantibody to c-Mpl (thrombopoietin receptor) in systemic lupus erythematosus: relationship to thrombocytopenia with megakaryocytic hypoplasia","volume":"46","author":"Kuwana","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib44","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2249.2006.03122.x","article-title":"Suspects in the tale of lupus-associated thrombocytopenia","volume":"145","author":"Ziakas","year":"2006","journal-title":"Clin Exp Immunol"},{"issue":"Suppl","key":"10.1053\/j.seminhematol.2008.12.005_bib45","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-0609.2007.00998.x","article-title":"Epidemiology and pathophysiology of immune thrombocytopenic purpura","author":"Gernsheimer","year":"2008","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib46","first-page":"75","article-title":"Treatment of severe immune thrombocytopenia associated with systemic lupus erythematosus: 59 cases","volume":"29","author":"Arnal","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib47","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1182\/blood.V84.12.4203.bloodjournal84124203","article-title":"Prevalence and clinical significance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic purpura","volume":"84","author":"Stasi","year":"1994","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib48","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1182\/blood.V98.6.1760","article-title":"Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study","volume":"98","author":"Diz-Kucukkaya","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib49","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/BF02724290","article-title":"Lupus anticoagulant in immune thrombocytopenic purpura","volume":"71","author":"Dash","year":"2004","journal-title":"Indian J Pediatr"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib50","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/ajh.20571","article-title":"Antiphospholipid antibodies (APLA) in immune thrombocytopenic purpura (ITP) and antiphospholipid syndrome (APS)","volume":"81","author":"Bidot","year":"2006","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib51","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2141.2004.05314.x","article-title":"Antiphospholipid antibodies in immune thrombocytopenic purpura tend to emerge in exacerbation and decline in remission","volume":"128","author":"Bidot","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib52","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1055\/s-0038-1642484","article-title":"Anti-glycoprotein Ib\/IX and IIb\/IIIa antibodies in patients with antiphospholipid antibodies","volume":"71","author":"Galli","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib53","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1046\/j.1365-2141.1997.2243038.x","article-title":"Anti-platelet antibodies in patients with systemic lupus erythematosus and the primary antiphospholipid antibody syndrome: their relationship with the observed thrombocytopenia","volume":"98","author":"Macchi","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib54","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1046\/j.1365-2141.1997.3063123.x","article-title":"Specific antiplatelet glycoprotein autoantibodies are associated with the thrombocytopenia of primary antiphospholipid syndrome","volume":"98","author":"Godeau","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib55","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1600-0609.1994.tb00195.x","article-title":"Specific antiplatelet autoantibodies in patients with antiphospholipid antibodies and thrombocytopenia","volume":"53","author":"Fabris","year":"1994","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib56","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/MOH.0b013e3282ab9904","article-title":"Secondary immune thrombocytopenic purpura","volume":"14","author":"Liebman","year":"2007","journal-title":"Curr Opin Hematol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib57","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1111\/j.1538-7836.2007.02605.x","article-title":"Platelets express three different splice variants of ApoER2 that are all involved in signaling","volume":"5","author":"Pennings","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib58","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1538-7836.2007.02310.x","article-title":"Platelet adhesion to dimeric beta-glycoprotein I under conditions of flow is mediated by at least two receptors: glycoprotein Ibalpha and apolipoprotein E receptor 2\u2032","volume":"5","author":"Pennings","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib59","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1002\/art.21968","article-title":"Anti-beta2-glycoprotein I antibodies in complex with beta2-glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib-IX-V","volume":"54","author":"Shi","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib60","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1055\/s-0037-1614491","article-title":"Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus\u2014possible association with thrombotic and thrombocytopenic complications","volume":"81","author":"Nojima","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib61","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/ajh.1182","article-title":"Correction of thrombocytopenia with aspirin in the primary antiphospholipid syndrome","volume":"68","author":"Alliot","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib62","first-page":"1359","article-title":"Correction of thrombocytopenia with small dose aspirin in the primary antiphospholipid syndrome","volume":"16","author":"Alarcon-Segovia","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib63","first-page":"803","article-title":"Multiple complications of the antiphospholipid syndrome with apparent response to aspirin therapy","volume":"19","author":"Cohen","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib64","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1210\/jcem-70-2-491","article-title":"Platelets in hyperthyroidism: studies on platelet counts, mean platelet volume, 111-indium-labeled platelet kinetics, and platelet-associated immunoglobulins G and M","volume":"70","author":"Panzer","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib65","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1046\/j.1365-2141.1998.00765.x","article-title":"Elevated numbers of reticulated platelets in hyperthyroidism: direct evidence for an increase of thrombopoiesis","volume":"101","author":"Stiegler","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib66","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.1365-2249.1998.00677.x","article-title":"Autoimmune thrombocytopenia (AITP) and thyroid autoimmune disease (TAD): overlapping syndromes?","volume":"113","author":"Cordiano","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib67","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1089\/thy.2007.0066","article-title":"Thyroid disease in patients with idiopathic thrombocytopenia: a cohort study","volume":"17","author":"Ioachimescu","year":"2007","journal-title":"Thyroid"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib68","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/ajh.20299","article-title":"Prevalence of elevated antithyroid antibodies and antinuclear antibodies in children with immune thrombocytopenic purpura","volume":"79","author":"Pratt","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib69","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2141.1982.00445.x","article-title":"The Evans syndrome: characterization of the responsible autoantibodies","volume":"51","author":"Pegels","year":"1982","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib70","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0022-3476(83)80705-7","article-title":"Autoimmune pancytopenia of childhood associated with multisystem disease manifestations","volume":"103","author":"Miller","year":"1983","journal-title":"J Pediatr"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib71","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ajh.2830150409","article-title":"Immunoregulatory abnormalities in Evans syndrome","volume":"15","author":"Wang","year":"1983","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib72","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0092-8674(95)90013-6","article-title":"Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome","volume":"81","author":"Fisher","year":"1995","journal-title":"Cell"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib73","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1126\/science.7539157","article-title":"Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity","volume":"268","author":"Rieux-Laucat","year":"1995","journal-title":"Science"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib74","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0140-6736(96)02293-3","article-title":"Clinical, immunological, and pathological consequences of Fas-deficient conditions","volume":"348","author":"Le Deist","year":"1996","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib75","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/sj.cdd.4401190","article-title":"Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways","volume":"10","author":"Rieux-Laucat","year":"2003","journal-title":"Cell Death Differ"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib76","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1182\/blood-2004-09-3542","article-title":"Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS)","volume":"105","author":"Teachey","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib77","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/jcp.39.7.713","article-title":"Autoimmunity in chronic lymphocytic leukaemia","volume":"39","author":"Hamblin","year":"1986","journal-title":"J Clin Pathol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib78","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1182\/blood.V84.5.1620.1620","article-title":"Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance?","volume":"84","author":"Dhodapkar","year":"1994","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib79","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1600-0609.1988.tb00853.x","article-title":"Idiopathic thrombocytopenic purpura and autoimmune hemolytic anemia in Hodgkin's disease","volume":"40","author":"Xiros","year":"1988","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib80","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/jnci\/djj361","article-title":"Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia","volume":"98","author":"Landgren","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib81","first-page":"669","article-title":"Incidence and prognostic significance of idiopathic thrombocytopenic purpura in patients with Hodgkin's disease in complete hematological remission","volume":"83","author":"Martinelli","year":"1998","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib82","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1053\/j.seminoncol.2006.01.011","article-title":"Autoimmune complications of chronic lymphocytic leukemia","volume":"33","author":"Hamblin","year":"2006","journal-title":"Semin Oncol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib83","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/10428199409051696","article-title":"Recurrence of autoimmune thrombocytopenia after treatment with fludarabine in a patient with chronic lymphocytic leukemia","volume":"15","author":"Montillo","year":"1994","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib84","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ajh.10024","article-title":"T-gamma large granular lymphocyte leukemia associated with amegakaryocytic thrombocytopenic purpura, Sjogren's syndrome, and polyglandular autoimmune syndrome type II, with subsequent development of pure red cell aplasia","volume":"69","author":"Ergas","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib85","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.leukres.2007.08.012","article-title":"Acquired amegakaryocytic thrombocytopenia and pure red cell aplasia associated with an occult large granular lymphocyte leukemia","volume":"32","author":"Lai","year":"2008","journal-title":"Leuk Res"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib86","doi-asserted-by":"crossref","first-page":"714","DOI":"10.7326\/0003-4819-96-6-714","article-title":"Autoimmune thrombocytopenic purpura in homosexual men","volume":"96","author":"Morris","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib87","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJM198409063111004","article-title":"On the mechanism of thrombocytopenic purpura in sexually active homosexual men","volume":"311","author":"Walsh","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib88","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7326\/0003-4819-104-1-47","article-title":"Antibodies to human T-lymphotropic virus type III and development of the acquired immunodeficiency syndrome in homosexual men presenting with immune thrombocytopenia","volume":"104","author":"Abrams","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib89","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2141.1987.tb06920.x","article-title":"Incidence and mechanism of neutropenia and thrombocytopenia in patients with human immunodeficiency virus infection","volume":"66","author":"Murphy","year":"1987","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib90","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2141.1987.tb01307.x","article-title":"Haematologic manifestations of the human immune deficiency virus (HIV)","volume":"66","author":"Zon","year":"1987","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib91","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJM199212173272503","article-title":"Kinetic studies of the mechanism of thrombocytopenia in patients with human immunodeficiency virus infection","volume":"327","author":"Ballem","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib92","first-page":"398","article-title":"HIV-related thrombocytopenia: four different clinical subsets","volume":"77","author":"Landonio","year":"1992","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib93","first-page":"415","article-title":"The mechanism of thrombocytopenia in patients with HIV infection","volume":"123","author":"Najean","year":"1994","journal-title":"J Lab Clin Med"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib94","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1182\/blood.V90.5.1787","article-title":"Infection of human marrow stroma by human immunodeficiency virus-1 (HIV-1) is both required and sufficient for HIV-1-induced hematopoietic suppression in vitro: demonstration by gene modification of primary human stroma","volume":"90","author":"Bahner","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib95","doi-asserted-by":"crossref","unstructured":"Moses A, Nelson J, Bagby GC Jr. The influence of human immunodeficiency virus-1 on hematopoiesis. Blood. 198;91:1479-95.","DOI":"10.1182\/blood.V91.5.1479"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib96","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1046\/j.1365-2141.1999.01169.x","article-title":"Megakaryocyte precursors, megakaryocytes and platelets express the HIV co-receptor CXCR4 on their surface: determination of response to stromal-derived factor-1 by megakaryocytes and platelets","volume":"104","author":"Kowalska","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib97","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3109\/10428190009148861","article-title":"HIV infection of megakaryocytic cell lines","volume":"36","author":"Sato","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib98","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1182\/blood.V75.10.1920.1920","article-title":"Internalization of human immunodeficiency virus type I and other retroviruses by megakaryocytes and platelets","volume":"75","author":"Zucker-Franklin","year":"1990","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib99","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood.V77.3.481.481","article-title":"Human immunodeficiency virus infection of megakaryocytic cells","volume":"77","author":"Sakaguchi","year":"1991","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib100","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1073\/pnas.86.14.5595","article-title":"Megakaryocytes of human immunodeficiency virus-infected individuals express viral RNA","volume":"86","author":"Zucker-Franklin","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib101","first-page":"1295","article-title":"Structural changes in the megakaryocytes of patients infected with the human immune deficiency virus (HIV-1)","volume":"134","author":"Zucker-Franklin","year":"1989","journal-title":"Am J Pathol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib102","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1073\/pnas.92.6.2263","article-title":"Sequestration of anti-platelet GPIIIa antibody in rheumatoid factor immune complexes of human immunodeficiency virus 1 thrombocytopenic patients","volume":"92","author":"Karpatkin","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib103","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1182\/blood-2005-01-0243","article-title":"Role of molecular mimicry to HIV-1 peptides in HIV-1-related immunologic thrombocytopenia","volume":"106","author":"Li","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib104","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1182\/blood.V80.1.162.162","article-title":"Presence of cross-reactive antibody between human immunodeficiency virus (HIV) and platelet glycoproteins in HIV-related immune thrombocytopenic purpura","volume":"80","author":"Bettaieb","year":"1992","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib105","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/0140-6736(93)92363-X","article-title":"Common epitope on HIV p24 and human platelets","volume":"342","author":"Hohmann","year":"1993","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib106","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0092-8674(01)00477-9","article-title":"Complement-independent, peroxide-induced antibody lysis of platelets in HIV-1-related immune thrombocytopenia","volume":"106","author":"Nardi","year":"2001","journal-title":"Cell"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib107","doi-asserted-by":"crossref","first-page":"9763","DOI":"10.1073\/pnas.85.24.9763","article-title":"Anti-human immunodeficiency virus type 1 antibody complexes on platelets of seropositive thrombocytopenic homosexuals and narcotic addicts","volume":"85","author":"Karpatkin","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib108","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1172\/JCI115593","article-title":"Autoimmune anti-HIV-1gp120 antibody with antiidiotype-like activity in sera and immune complexes of HIV-1-related immunologic thrombocytopenia","volume":"89","author":"Karpatkin","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib109","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1182\/blood-2004-01-0386","article-title":"Identification of talin head domain as an immunodominant epitope of the antiplatelet antibody response in patients with HIV-1-associated thrombocytopenia","volume":"104","author":"Koefoed","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib110","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1365-2141.2005.05542.x","article-title":"Hepatitis C virus-related thrombocytopenia: clinical and laboratory characteristics compared with chronic immune thrombocytopenic purpura","volume":"129","author":"Rajan","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib111","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11894-001-0044-1","article-title":"Extrahepatic manifestations of chronic viral hepatitis","volume":"3","author":"Pyrsopoulos","year":"2001","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib112","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1111\/j.1572-0241.2002.05845.x","article-title":"Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection","volume":"97","author":"Pockros","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib113","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1440-1746.1994.tb01223.x","article-title":"Type C chronic hepatitis associated with thrombocytopenia in two patients","volume":"9","author":"Yabu","year":"1994","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib114","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1172\/JCI105380","article-title":"Pooling of platelets in the spleen: role in the pathogenesis of \u201chypersplenic\u201d thrombocytopenia","volume":"45","author":"Aster","year":"1966","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib115","first-page":"1404","article-title":"Thrombocytopenia associated with liver cirrhosis and hepatitis C viral infection: role of thrombopoietin","volume":"47","author":"Espanol","year":"2000","journal-title":"Hepatogastroenterology"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib116","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1046\/j.1365-2141.2001.02824.x","article-title":"Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis","volume":"113","author":"Adinolfi","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib117","first-page":"734","article-title":"[Study on the influencing factors of thrombocytopenia in viral hepatitis]","volume":"12","author":"Jiang","year":"2004","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib118","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0168-8278(97)80291-7","article-title":"Is inadequate thrombopoietin production a major cause of thrombocytopenia in cirrhosis of the liver?","volume":"27","author":"Peck-Radosavljevic","year":"1997","journal-title":"J Hepatol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib119","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/gut.44.5.754","article-title":"Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation","volume":"44","author":"Goulis","year":"1999","journal-title":"Gut"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib120","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.0902-4441.2006.t01-1-EJH2888.x","article-title":"Platelet autoantibodies are common in hepatitis C infection, irrespective of the presence of thrombocytopenia","volume":"77","author":"Panzer","year":"2006","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib121","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1182\/blood.V98.8.2293","article-title":"The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines","volume":"98","author":"Hamaia","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib122","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1053\/jhep.2003.50209","article-title":"A role of autoantibody-mediated platelet destruction in thrombocytopenia in patients with cirrhosis","volume":"37","author":"Kajihara","year":"2003","journal-title":"Hepatology"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib123","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1386-6346(02)00010-4","article-title":"Mechanisms for increment of platelet associated IgG and platelet surface IgG and their implications in immune thrombocytopenia associated with chronic viral liver disease","volume":"24","author":"Doi","year":"2002","journal-title":"Hepatol Res"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib123a","unstructured":"Zhang W, Nardi MA, Borkowsky W, Karpatkin S. Role of molecular mimicry of hepatitis C virus (HCV) protein with platelet GPIIIa in hepatitis-C related immunologic thrombocytopenia. Blood. In press."},{"issue":"Suppl 13","key":"10.1053\/j.seminhematol.2008.12.005_bib124","first-page":"S39","article-title":"A laboratory and thrombokinetic study of HCV-associated thrombocytopenia: a direct role of HCV in bone marrow exhaustion?","volume":"13","author":"Bordin","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib125","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00277-004-0844-0","article-title":"Hepatitis C virus-associated thrombocytopenia: a controlled prospective, virological study","volume":"83","author":"de Almeida","year":"2004","journal-title":"Ann Hematol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib126","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1600-0609.2005.00524.x","article-title":"Improvement of thrombocytopenia with disappearance of HCV RNA in patients treated by interferon-alpha therapy: possible etiology of HCV-associated immune thrombocytopenia","volume":"75","author":"Iga","year":"2005","journal-title":"Eur J Haematol"},{"issue":"Suppl D","key":"10.1053\/j.seminhematol.2008.12.005_bib127","article-title":"Thrombocytopenia in liver disease","volume":"14","author":"Peck-Radosavljevic","year":"2000","journal-title":"Can J Gastroenterol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib128","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1056\/NEJMoa073255","article-title":"Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C","volume":"357","author":"McHutchison","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib129","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1182\/blood-2003-03-0900","article-title":"Does Helicobater pylori initiate or perpetuate immune thrombocytopenic purpura?","volume":"103","author":"Michel","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib130","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0140-6736(05)60004-9","article-title":"Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori","volume":"352","author":"Gasbarrini","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib131","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/gut.42.3.338","article-title":"Major virulence factors, VacA and CagA, are commonly positive in Helicobacter pylori isolates in Japan","volume":"42","author":"Maeda","year":"1998","journal-title":"Gut"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib132","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1136\/gut.44.3.336","article-title":"Structure of cag pathogenicity island in Japanese Helicobacter pylori isolates","volume":"44","author":"Maeda","year":"1999","journal-title":"Gut"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib133","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1182\/blood-2006-12-063222","article-title":"Helicobacter pylori infection and chronic immune thrombocytopenic purpura: long-term results of bacterium eradication and association with bacterium virulence profiles","volume":"110","author":"Emilia","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib134","doi-asserted-by":"crossref","first-page":"766","DOI":"10.7326\/0003-4819-140-9-200405040-00028","article-title":"Helicobacter pylori and idiopathic thrombocytopenic purpura","volume":"140","author":"Franceschi","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib135","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1365-2141.2003.04735.x","article-title":"Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori-associated chronic idiopathic thrombocytopenic purpura","volume":"124","author":"Takahashi","year":"2004","journal-title":"Br J Haematol"},{"issue":"Suppl 1","key":"10.1053\/j.seminhematol.2008.12.005_bib136","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1523-5378.7.s1.3.x","article-title":"Pathogenesis of Helicobacter pylori infection","volume":"7","author":"Gerhard","year":"2002","journal-title":"Helicobacter"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib137","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/S0016-5085(03)00397-4","article-title":"Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation","volume":"124","author":"Byrne","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib138","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1182\/blood-2007-08-105411","article-title":"Inside Blood; ITP: time to \u201cbug off\u201d?","volume":"110","author":"Cines","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib139","first-page":"2939","article-title":"Helicobacter pylori eradication shifts monocyte Fcgamma receptor balance toward inhibitory FcgammaRIIB in immune thrombocytopenic purpura patients","volume":"118","author":"Asahi","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib140","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/09537100400028685","article-title":"Analysis of B- and T-cell clonality and HLA class II alleles in patients with idiopathic thrombocytopenic purpura: correlation with Helicobacter pylori infection and response to eradication treatment","volume":"16","author":"Veneri","year":"2005","journal-title":"Platelets"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib141","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.amjmed.2004.09.014","article-title":"Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpura","volume":"118","author":"Stasi","year":"2005","journal-title":"Am J Med"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib142","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/adc.84.3.227","article-title":"Idiopathic thrombocytopenic purpura and MMR vaccine","volume":"84","author":"Miller","year":"2001","journal-title":"Arch Dis Child"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib143","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jama.287.4.505","article-title":"US immunization policy","volume":"287","author":"Abramson","year":"2002","journal-title":"JAMA"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib144","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2125.2003.01790.x","article-title":"MMR vaccine and idiopathic thrombocytopaenic purpura","volume":"55","author":"Black","year":"2003","journal-title":"Br J Clin Pharmacol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib145","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1016\/j.vaccine.2005.03.005","article-title":"Consequence or coincidence?","volume":"23","author":"Schattner","year":"2005","journal-title":"Vaccine"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib146","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/003655498750003465","article-title":"Immune thrombocytopenic purpura after recombinant hepatitis B vaccine: retrospective study of seven cases","volume":"30","author":"Neau","year":"1998","journal-title":"Scand J Infect Dis"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib147","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/archneur.1983.04050080052009","article-title":"CNS lesions in neonatal isoimmune thrombocytopenia","volume":"40","author":"Naidu","year":"1983","journal-title":"Arch Neurol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib148","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/00006454-199601000-00020","article-title":"Thrombocytopenia after immunization with measles vaccines: review of the vaccine adverse events reporting system (1990 to 1994)","volume":"15","author":"Beeler","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib149","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1651-2227.1993.tb12657.x","article-title":"Acute thrombocytopenic purpura following measles, mumps and rubella vaccination","volume":"82","author":"Nieminen","year":"1993","journal-title":"Acta Paediatr"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib150","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/01.inf.0000048961.08486.d1","article-title":"Thrombocytopenia after immunization of Canadian children, 1992 to 2001","volume":"22","author":"Jadavji","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib151","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1309\/4FMBN316N4792UQ4","article-title":"Human herpesvirus type 8 in patients with cirrhosis: correlation with sex, alcoholism, hepatitis B virus, disease severity, and thrombocytopenia","volume":"130","author":"Chou","year":"2008","journal-title":"Am J Clin Pathol"},{"issue":"Suppl 1","key":"10.1053\/j.seminhematol.2008.12.005_bib152","first-page":"S10","article-title":"Review of clinical symptoms and spectrum in humans with influenza A\/H5N1 infection","volume":"13","author":"Hui","year":"2008","journal-title":"Respirology"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib153","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1743-422X-5-47","article-title":"Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review","volume":"5","author":"Rafailidis","year":"2008","journal-title":"Virol J"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib154","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/10245330400026170","article-title":"Thrombocytopenia in patients with severe acute respiratory syndrome (review)","volume":"10","author":"Yang","year":"2005","journal-title":"Hematology"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib155","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(02)39906-9","article-title":"Quinine as a cause of purpura","volume":"2","author":"Vipan","year":"1865","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib157","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMra066469","article-title":"Drug-induced immune thrombocytopenia","volume":"357","author":"Aster","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib158","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.2165\/00002018-200427150-00007","article-title":"Drug-induced immune thrombocytopenia","volume":"27","author":"van den Bemt","year":"2004","journal-title":"Drug Saf"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib159","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1182\/blood.V77.12.2668.2668","article-title":"Characteristics of quinine- and quinidine-induced antibodies specific for platelet glycoproteins IIb and IIIa","volume":"77","author":"Visentin","year":"1991","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib160","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1182\/blood-2002-07-2175","article-title":"Drug-induced thrombocytopenia: localization of the binding site of GPIX-specific quinine-dependent antibodies","volume":"102","author":"Asvadi","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib161","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/art.1780240808","article-title":"Hapten immunology and allergic reactions in humans","volume":"24","author":"Parker","year":"1981","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib162","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1182\/blood-2006-01-009803","article-title":"Patients with quinine-induced immune thrombocytopenia have both \u201cdrug-dependent\u201d and \u201cdrug-specific\u201d antibodies","volume":"108","author":"Bougie","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib163","doi-asserted-by":"crossref","first-page":"53S","DOI":"10.1378\/chest.127.2_suppl.53S","article-title":"Immune thrombocytopenia caused by glycoprotein IIb\/IIIa inhibitors","volume":"127","author":"Aster","year":"2005","journal-title":"Chest"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib164","first-page":"E173","article-title":"Fatal delayed thrombocytopenia following abciximab therapy","volume":"18","author":"McCorry","year":"2006","journal-title":"J Invasive Cardiol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib165","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1182\/blood.V99.6.2054","article-title":"Thrombocytopenia after second exposure to abciximab is caused by antibodies that recognize abciximab-coated platelets","volume":"99","author":"Curtis","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib166","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/hc3301.094533","article-title":"Abciximab readministration: results of the ReoPro Readministration Registry","volume":"104","author":"Tcheng","year":"2001","journal-title":"Circulation"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib167","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1538-7836.2004.00744.x","article-title":"Delayed thrombocytopenia after treatment with abciximab: a distinct clinical entity associated with the immune response to the drug","volume":"2","author":"Curtis","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib168","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2141.1986.tb07528.x","article-title":"Thrombocytopenia associated with gold therapy: a drug-induced autoimmune disease?","volume":"63","author":"von dem Borne","year":"1986","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib169","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1182\/blood.V100.1.344","article-title":"Glycoprotein V: the predominant target antigen in gold-induced autoimmune thrombocytopenia","volume":"100","author":"Garner","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib170","doi-asserted-by":"crossref","first-page":"886","DOI":"10.7326\/0003-4819-129-11_Part_1-199812010-00009","article-title":"Drug-induced thrombocytopenia: a systematic review of published case reports","volume":"129","author":"George","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib171","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/archinte.164.4.361","article-title":"Treatment of heparin-induced thrombocytopenia: a critical review","volume":"164","author":"Hirsh","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib172","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0002-9343(96)00258-6","article-title":"A 14-year study of heparin-induced thrombocytopenia","volume":"101","author":"Warkentin","year":"1996","journal-title":"Am J Med"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib173","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1378\/chest.122.1.37","article-title":"Heparin-induced thrombocytopenia: temporal pattern of thrombocytopenia in relation to initial use or reexposure to heparin","volume":"122","author":"Lubenow","year":"2002","journal-title":"Chest"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib174","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJM200104263441704","article-title":"Temporal aspects of heparin-induced thrombocytopenia","volume":"344","author":"Warkentin","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib175","doi-asserted-by":"crossref","first-page":"502","DOI":"10.7326\/0003-4819-135-7-200110020-00009","article-title":"Delayed-onset heparin-induced thrombocytopenia and thrombosis","volume":"135","author":"Warkentin","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib176","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1182\/blood.V98.8.2442","article-title":"Heparin-induced thrombocytopenia\/thrombosis in a transgenic mouse model requires human platelet factor 4 and platelet activation through FcgammaRIIA","volume":"98","author":"Reilly","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib177","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1182\/blood-2004-04-1544","article-title":"Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia","volume":"105","author":"Rauova","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib178","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1182\/blood-2005-08-3122","article-title":"Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications","volume":"107","author":"Rauova","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib179","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM198703053161004","article-title":"Immune endothelial-cell injury in heparin-associated thrombocytopenia","volume":"316","author":"Cines","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib180","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1182\/blood.V98.4.1252","article-title":"Antibodies from patients with heparin-induced thrombocytopenia stimulate monocytic cells to express tissue factor and secrete interleukin-8","volume":"98","author":"Arepally","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib181","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1179\/102453308X316176","article-title":"Heparin induced thrombocytopenia with thrombosis: a two step process?","volume":"13","author":"Thachil","year":"2008","journal-title":"Hematology"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib182","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1161\/01.CIR.95.5.1242","article-title":"Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery","volume":"95","author":"Bauer","year":"1997","journal-title":"Circulation"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib183","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/j.1538-7836.2008.03025.x","article-title":"Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays","volume":"6","author":"Warkentin","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib184","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1468-0734.2001.00041.x","article-title":"Drug-induced and drug-dependent immune thrombocytopenias","volume":"5","author":"Greinacher","year":"2001","journal-title":"Rev Clin Exp Hematol"},{"key":"10.1053\/j.seminhematol.2008.12.005_bib185","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1053\/j.seminhematol.2007.11.004","article-title":"Other immune thrombocytopenias","volume":"44","author":"Liebman","year":"2007","journal-title":"Semin Hematol"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196308002047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196308002047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:20:18Z","timestamp":1758522018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196308002047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":185,"alternative-id":["S0037196308002047"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2008.12.005","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathobiology of Secondary Immune Thrombocytopenia","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2008.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}